.

Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Johnson and Johnson
Baxter
Citi
UBS
Chubb
Federal Trade Commission
Queensland Health
Daiichi Sankyo
Colorcon

Generated: December 16, 2017

DrugPatentWatch Database Preview

Sulindac - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for sulindac and what is the scope of sulindac freedom to operate?

Sulindac
is the generic ingredient in two branded drugs marketed by Merck, Ani Pharms Inc, Epic Pharma, Epic Pharma Llc, Mylan, Sandoz, Sun Pharm Industries, and Watson Labs, and is included in thirteen NDAs. Additional information is available in the individual branded drug profile pages.

There are fourteen drug master file entries for sulindac. Twenty-two suppliers are listed for this compound.

Pharmacology for sulindac

Medical Subject Heading (MeSH) Categories for sulindac

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Epic Pharma LlcSULINDACsulindacTABLET;ORAL073262-001Sep 6, 1991ABRXNoNo► Subscribe► Subscribe► Subscribe
MylanSULINDACsulindacTABLET;ORAL073039-002Jun 22, 1993ABRXNoNo► Subscribe► Subscribe► Subscribe
Epic Pharma LlcSULINDACsulindacTABLET;ORAL073262-002Sep 6, 1991ABRXNoNo► Subscribe► Subscribe► Subscribe
Epic PharmaSULINDACsulindacTABLET;ORAL072711-001Mar 25, 1991ABRXNoNo► Subscribe► Subscribe► Subscribe
MylanSULINDACsulindacTABLET;ORAL073039-001Jun 22, 1993ABRXNoNo► Subscribe► Subscribe► Subscribe
Epic PharmaSULINDACsulindacTABLET;ORAL072710-001Mar 25, 1991ABRXNoNo► Subscribe► Subscribe► Subscribe
MerckCLINORILsulindacTABLET;ORAL017911-002Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
SandozSULINDACsulindacTABLET;ORAL072712-001Aug 30, 1991DISCNNoNo► Subscribe► Subscribe► Subscribe
Ani Pharms IncSULINDACsulindacTABLET;ORAL072972-001Feb 28, 1992DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson LabsSULINDACsulindacTABLET;ORAL071795-001Apr 3, 1990ABRXNoYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: sulindac

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
MerckCLINORILsulindacTABLET;ORAL017911-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
MerckCLINORILsulindacTABLET;ORAL017911-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
MerckCLINORILsulindacTABLET;ORAL017911-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
MerckCLINORILsulindacTABLET;ORAL017911-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Queensland Health
Daiichi Sankyo
Harvard Business School
Cipla
AstraZeneca
Teva
Express Scripts
Colorcon
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot